Sign in
4

Changes in Ownership

Edgewise Therapeutics, Inc. Filed Acc 0001562180-22-005126

General Counsel sold 26,381 shares at an average $6.08 ($160,457)

  • General Counsel acquired 26,381 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

MOORE JOHN R · General Counsel

Table I: Non-derivative

8 lines
Date Transaction Shares Price Value Owned after D/I
2022-06-13 Exercise or conversion : show line 1 in the form +4,093 $0.71 $2,906 7,093 D
2022-06-13 Sale : show line 2 in the form −4,093 $6.01 $24,582 3,000 D
2022-06-14 Exercise or conversion : show line 3 in the form +3,628 $0.71 $2,576 6,628 D
2022-06-14 Sale : show line 4 in the form −3,628 $6.02 $21,855 3,000 D
2022-06-15 Exercise or conversion : show line 5 in the form +18,075 $0.71 $12,833 21,075 D
2022-06-15 Exercise or conversion : show line 6 in the form +585 $1.93 $1,129 21,660 D
2022-06-15 Sale : show line 7 in the form −585 $6.11 $3,575 21,075 D
2022-06-15 Sale : show line 8 in the form −18,075 $6.11 $110,445 3,000 D
Open-market sales · 26,381 sh · avg $6.08 · $160,457

Table II: Derivative

4 lines
Date Transaction Shares Owned after D/I
2022-06-13 Exercise or conversion : show line 9 in the form Stock Option (Right to Buy) −4,093 156,773 D
2022-06-14 Exercise or conversion : show line 10 in the form Stock Option (Right to Buy) −3,628 153,145 D
2022-06-15 Exercise or conversion : show line 11 in the form Stock Option (Right to Buy) −18,075 135,070 D
2022-06-15 Exercise or conversion : show line 12 in the form Stock Option (Right to Buy) −585 196,336 D
Loading xslF345X03/primarydocument.xml…